Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients

Xu,Zhen; Lin,Ji‑Zong; Lin,Guo‑Li; Wei,Fang‑Fang; Liu,Jing; Zhao,Zhi‑Xin; Zhang,Ying; Ke,Wei‑Ming; Zhang,Xiao‑Hong

doi:10.3892/etm.2016.3915

Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients

Authors:
- Zhen Xu
- Ji‑Zong Lin
- Guo‑Li Lin
- Fang‑Fang Wei
- Jing Liu
- Zhi‑Xin Zhao
- Ying Zhang
- Wei‑Ming Ke
- Xiao‑Hong Zhang
View Affiliations

Affiliations: Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510630, P.R. China, Department of General Surgery, Lingnan Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510530, P.R. China
Published online on: November 18, 2016 https://doi.org/10.3892/etm.2016.3915
Pages: 155-159
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The association between serum hepatitis C virus (HCV) load and hepatic injury in HCV‑infected patients has been extensively investigated. The present study aimed to investigate the association between HCV load in hepatic parenchyma cells and hepatic injury in HCV‑infected patients. A total of 56 HCV‑infected patients were included in the present retrospective study. The serum HCV mRNA was determined using quantitative polymerase chain reaction, while the hepatic parenchyma cell volume and HCV mRNA in hepatic parenchyma cells were also determined. Hepatic injury was evaluated on the basis of the severity of inflammation and fibrosis. The results demonstrated that there were evident differences in the mean serum HCV RNA levels and the HCV load/parenchyma cell volume among the various grades of hepatic inflammation (G1‑G4) when groups with the least and most inflammation were compared (G1 vs. G4; P<0.05). Significant differences in the HCV load existed between groups divided according to the fibrosis grade; in addition, differences existed between fibrosis grades S1 and S2, and S2 and S4 when comparing serum HCV RNA levels (P<0.05). Similarly, differences existed between every two fibrosis stages (S0 vs. S4, S2 vs. S3, and S2 vs. S4; P<0.05) when viral loads and parenchyma cell volumes were compared (F=2.860, P<0.05). Furthermore, the fibrosis staging was correlated with the viral load/parenchyma cell volume (F=2.670, P<0.05). In conclusion, hepatic fibrosis grade was found to be associated with HCV load in parenchyma cells. The results of the present study demonstrated that the viral load in parenchyma cells is a more appropriate index compared with the serum viral load for evaluating HCV replication in hepatocytes, and may function as an important factor in HCV‑infected hepatic injury evaluation.

View Figures

View References

1	Hajarizadeh B, Grebely J and Dore GJ: Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 10:553–562. 2013. View Article : Google Scholar : PubMed/NCBI
2	Lavanchy D: Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 17:107–115. 2011. View Article : Google Scholar : PubMed/NCBI
3	Bartenschlager R: Hepatitis C virus: From molecular virology to antiviral therapy. Current Topics in Microbiology & Immunology. 369:V–VI. 2013.
4	Hernandez-Gea V and Friedman SL: Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011. View Article : Google Scholar : PubMed/NCBI
5	Alberti A and Benvegnù L: Management of hepatitis C. J Hepatol. 38:Suppl 1. S104–118. 2003. View Article : Google Scholar : PubMed/NCBI
6	Marcellin P, Asselah T and Boyer N: Fibrosis and disease progression in hepatitis C. Hepatology. 36(5): Suppl 1. S47–S56. 2002. View Article : Google Scholar : PubMed/NCBI
7	Zeuzem S, Alberti A, Rosenberg W, Marcellin P, Diago M, Negro F, Prati D, Puoti C, Roberts SK and Shiffman ML: Review article: Management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity. Aliment Pharmacol Ther. 24:1133–1149. 2006. View Article : Google Scholar : PubMed/NCBI
8	Adinolfi LE, Utili R, Andreana A, Tripodi MF, Marracino M, Gambardella M, Giordano M and Ruggiero G: Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci. 46:1677–1683. 2001. View Article : Google Scholar : PubMed/NCBI
9	Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P and Hillon P: Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol. 98:1150–1154. 2003. View Article : Google Scholar : PubMed/NCBI
10	Durante-Mangoni E, Zampino R, Portella G, Adinolfi LE, Utili R and Ruggiero G: Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment. Clin Infect Dis. 49:498–506. 2009. View Article : Google Scholar : PubMed/NCBI
11	Hsu CS, Liu CH, Liu CJ, Chen CL, Lai MY, Chen PJ, Chen DS and Kao JH: Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy. Antivir Ther. 14:45–54. 2009.PubMed/NCBI
12	Ke WM, Xie SB, Yu LN, Liu T, Lai J, He DQ, Li XH, Gao ZL, Ke Y and Chen PJ: Decline of serum HBV DNA and no change apportioned by the same hepatic parenchyma cell volume from hepatic fibrosis stage 1 to stage 4 during the natural history of chronic hepatitis B. Intervirology. 51:235–240. 2008. View Article : Google Scholar : PubMed/NCBI
13	Lee YS, Yoon SK, Chung ES, Bae SH, Choi JY, Han JY, Chung KW, Sun HS, Kim BS and Kim BK: The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C. J Korean Med Sci. 16:585–591. 2001. View Article : Google Scholar : PubMed/NCBI
14	Chinese Medical Association, . Viral hepatitis prevention and treatment programs. Chuan Ran Bing Xin Xi. 13:141–150. 2000.(In Chinese).
15	Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al: Histological grading and staging of chronic hepatitis. J Hepatol. 22:696–699. 1995. View Article : Google Scholar : PubMed/NCBI
16	Desmet VJ, Gerber M, Hoofnagle JH, Manns M and Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 19:1513–1520. 1994. View Article : Google Scholar : PubMed/NCBI
17	Xie SB, Yao JL, Zheng SS, Yao CL and Zheng RQ: The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis. Hepatobiliary Pancreat Dis Int. 1:202–206. 2002.PubMed/NCBI
18	Ke WM, Xie SB, Li XJ, Zhang SQ, Lai J, Ye YN, Gao ZL and Chen PJ: There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume. J Viral Hepat. 18:637–645. 2011. View Article : Google Scholar : PubMed/NCBI
19	Kar P: Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol. 4:(Suppl 3). S34–S42. 2014. View Article : Google Scholar : PubMed/NCBI
20	Cerny A and Chisari FV: Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology. 30:595–601. 1999. View Article : Google Scholar : PubMed/NCBI
21	Rehermann B: Interaction between the hepatitis C virus and the immune system. Semin Liver Dis. 20:127–141. 2000. View Article : Google Scholar : PubMed/NCBI
22	Anand BS and Velez M: Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol. 10:2409–2411. 2004. View Article : Google Scholar : PubMed/NCBI
23	Bacon BR: Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology. 36:(Suppl 1). S179–S184. 2002. View Article : Google Scholar : PubMed/NCBI
24	Leone N and Rizzetto M: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol. 51:31–46. 2005.(In English and Italian). PubMed/NCBI
25	Orellana NI, Poniachik TJ, Smok SG, Madrid SAM, Menéndez AA, Tobar AE and Brahm BJ: Factors associated with the severity of liver damage in chronic hepatitis C. Rev Med Chil. 133:1311–1316. 2005.(In Spanish). PubMed/NCBI
26	Ramos Gómez M: Natural history of chronic hepatitis C. Rev Gastroenterol Mex 67 Suppl. 2:S17–S20. 2002.(In Spanish).
27	Zechini B, Pasquazzi C and Aceti A: Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: The role of serum aspartate transaminase in the evaluation of disease progression. Eur J Gastroenterol Hepatol. 16:891–896. 2004. View Article : Google Scholar : PubMed/NCBI
28	Shen L, Li JQ, Zeng MD, Fan ST, Lu LG, Bao H and Cao AP: Evaluation of the value of ultrasonography in diagnosis of liver fibrosis in patients with chronic viral hepatitis. Zhonghua Gan Zang Bing Za Zhi. 13:117–120. 2005.(In Chinese). PubMed/NCBI
29	Umbetova KT, Volchkova EV, Kiselevskiĭ MV, Lazareva AS and Pak SG: Lymphocyte subpopulation composition in hepatic tissue and autoimmune manifestations in viral hepatitis. Vestn Ross Akad Med Nauk. 12:37–40. 2010.